DCF — UNIVERSITY HOSPITAL OF BROOKLYN
Enterprise Value: $-321.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-321.2M
Enterprise Value
$-107.4M
PV of Cash Flows
$-213.7M
PV of Terminal Value
$-344.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $374.0M | $-16.8M | -5.0% | $-32.7M | $-29.7M |
| Year 2 | $385.2M | $-13.5M | -4.0% | $-29.8M | $-24.6M |
| Year 3 | $396.8M | $-9.9M | -3.0% | $-26.7M | $-20.1M |
| Year 4 | $408.7M | $-8.2M | -2.0% | $-25.5M | $-17.4M |
| Year 5 | $421.0M | $-7.4M | -2.0% | $-25.2M | $-15.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-321.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$363.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.05
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5